RPL22 is a tumor suppressor in MSI-high cancers and a key splicing regulator of MDM4
Hannah N. W. Weinstein, Kevin Hu, Lisa Fish…·Franklin W. Huang
This study identifies RPL22 as a tumor suppressor in MSI-H cancers that regulates MDM4 splicing and reveals its role in oncogenic pathways.